213 related articles for article (PubMed ID: 18032952)
1. HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma.
Schlauder SM; Calder KB; Moody P; Morgan MB
Am J Dermatopathol; 2007 Dec; 29(6):559-63. PubMed ID: 18032952
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin.
Maubec E; Duvillard P; Velasco V; Crickx B; Avril MF
Anticancer Res; 2005; 25(2B):1205-10. PubMed ID: 15865067
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
[TBL] [Abstract][Full Text] [Related]
5. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
Wei Q; Sheng L; Shui Y; Hu Q; Nordgren H; Carlsson J
Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
[TBL] [Abstract][Full Text] [Related]
6. EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases.
Wei Q; Chen L; Sheng L; Nordgren H; Wester K; Carlsson J
Int J Oncol; 2007 Sep; 31(3):493-9. PubMed ID: 17671674
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
Weinberger PM; Yu Z; Kowalski D; Joe J; Manger P; Psyrri A; Sasaki CT
Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):707-11. PubMed ID: 16103303
[TBL] [Abstract][Full Text] [Related]
9. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: possible implications for targeted therapy.
Shang J; Shui Y; Sheng L; Wang K; Hu Q; Wei Q
Oncol Rep; 2008 Feb; 19(2):435-40. PubMed ID: 18202792
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholine receptor expression in Merkel cell carcinoma.
Bowers JW; Schlauder SM; Calder KB; Morgan MB
Am J Dermatopathol; 2008 Aug; 30(4):340-3. PubMed ID: 18645305
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor expression is predictive of poor prognosis in feline cutaneous squamous cell carcinoma.
Sabattini S; Marconato L; Zoff A; Morini M; Scarpa F; Capitani O; Bettini G
J Feline Med Surg; 2010 Oct; 12(10):760-8. PubMed ID: 20674427
[TBL] [Abstract][Full Text] [Related]
15. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.
Laimer K; Spizzo G; Gastl G; Obrist P; Brunhuber T; Fong D; Barbieri V; Jank S; Doppler W; Rasse M; Norer B
Oral Oncol; 2007 Feb; 43(2):193-8. PubMed ID: 16854613
[TBL] [Abstract][Full Text] [Related]
16. Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer.
Fink-Retter A; Gschwantler-Kaulich D; Hudelist G; Mueller R; Kubista E; Czerwenka K; Singer CF
Oncol Rep; 2007 Aug; 18(2):299-304. PubMed ID: 17611648
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.
Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210
[TBL] [Abstract][Full Text] [Related]
19. Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.
Grenier J; Soria JC; Mathieu MC; Andre F; Abdelmoula S; Velasco V; Morat L; Besse B; Dunant A; Spielmann M; Delaloge S
Anticancer Res; 2007; 27(1B):547-55. PubMed ID: 17348440
[TBL] [Abstract][Full Text] [Related]
20. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
